{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/bronchiectasis/prescribing-information/amoxicillin/","result":{"pageContext":{"chapter":{"id":"a98b5813-5589-5247-9c65-e9ae534d88c2","slug":"amoxicillin","fullItemName":"Amoxicillin","depth":2,"htmlHeader":"<!-- begin field 5b5df68a-22dd-4442-92d8-d52483c89fa8 --><h2>Amoxicillin</h2><!-- end field 5b5df68a-22dd-4442-92d8-d52483c89fa8 -->","summary":"","htmlStringContent":"<!-- begin item 51129b8b-b266-413c-8c0a-1a6a373c7df3 --><!-- end item 51129b8b-b266-413c-8c0a-1a6a373c7df3 -->","topic":{"id":"96a8622b-46f5-55fa-b729-6748e3d98c98","topicId":"26fab339-e333-44ec-a481-de87a29052f3","topicName":"Bronchiectasis","slug":"bronchiectasis","lastRevised":"Last revised in January 2021","chapters":[{"id":"43d88c30-f768-5e1c-a6ea-5596c5577fb5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ac4fde9a-5fd3-5ed9-9201-f714bda470bb","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0b34af83-d49a-5145-8589-e8748b8646c0","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"04eeb1ae-4fc3-5418-83a2-b62587d8bdda","slug":"changes","fullItemName":"Changes"},{"id":"dbd8ad5a-871c-59b8-9729-444e11ac9df1","slug":"update","fullItemName":"Update"}]},{"id":"b89644c6-805f-50b4-991d-36bb2b0fbf67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d38de329-73b8-5fed-83ef-f836b765cd3f","slug":"goals","fullItemName":"Goals"},{"id":"3c116665-5586-5551-909c-0efc1ef0be62","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"60e13bc0-e351-5c39-b8ff-9a8d4514bf16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2ee37cc0-9ff4-5bbd-ab3f-0a30cb904bb5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d155aa4f-7dfe-575d-a7dd-a87774f4cbad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"07c3e24b-c950-516e-9070-5441a07b3791","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5146c866-f0a7-54a6-a5ac-8aff4b385cc6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e2107a7e-b7c3-5ba9-94e4-6217ea79a3f2","slug":"definition","fullItemName":"Definition"},{"id":"39df7c47-de08-57ae-aa40-89a7d4d7b031","slug":"causes","fullItemName":"Causes"},{"id":"ac4d346e-97d4-5d84-a704-fbdcf56be7f4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e07a8b0b-866c-5789-85ef-020a5b19b620","slug":"prognosis-complications","fullItemName":"Prognosis and complications"}]},{"id":"ef5c5e7b-3cf4-5939-85e0-b61cae41f945","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ce267b5b-70dd-52bd-ad83-6123bd42fa0d","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"c605c0b9-0519-50e1-abd8-2dc47de7278a","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"23a1627d-30f7-5ba4-95f8-060faf797f51","slug":"suspected-infective-exacerbation-diagnosis","fullItemName":"Suspected infective exacerbation diagnosis"}]},{"id":"5a5846fa-c8b4-5cd4-b2d3-770c3dc00ba2","fullItemName":"Management","slug":"management","subChapters":[{"id":"0180d43c-dd8d-5a87-915c-629542f782fe","slug":"suspected-bronchiectasis","fullItemName":"Scenario: Suspected bronchiectasis"},{"id":"290c51ae-6521-5c03-b12e-117e40c88883","slug":"infective-exacerbation","fullItemName":"Scenario: Infective exacerbation"},{"id":"1e90ec28-8eea-5ab7-ac76-2df1ace279de","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"ba1a593e-f80b-5c5f-be50-5979b491bc70","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6db0266e-4d15-5eec-b2c0-ed20f472eeb5","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"a98b5813-5589-5247-9c65-e9ae534d88c2","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"04c99c8f-7a1d-55f0-85a2-6d0e1bc3e4e3","slug":"ciprofloxacin","fullItemName":"Ciprofloxacin"},{"id":"26b521e3-9c5e-5a7c-956b-7f3f39f2e58c","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"6cd6079a-be84-5279-9d10-e3bf4653c049","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"8ed4a900-3e69-51c0-8cd5-c2b0bee9bfe2","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"5217d027-064d-5543-93b0-7e8bb1a1c0fc","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"cf1fbf18-e60a-54f7-bbc4-2a30ab37f565","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"8e888abe-cb05-5343-b6e3-547dea7312cc","slug":"beta-2-agonists","fullItemName":"Beta-2 agonists"}]},{"id":"118b4e08-e6ae-510a-b2f5-51b109ef3395","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ecf8de37-d8f0-5ced-af38-9be20fa73de9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1c227675-02ea-5c9e-a927-e385987adf53","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f74bbe64-1998-528f-b811-df2a14219de7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2a925d45-6865-5cd5-9624-23da53ee221a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a6ff3076-9be6-55b4-b373-f40cb3045f2c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"67608f46-5eba-58f9-86e3-0e0e3f57d921","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3fae7f8d-20fb-5fe6-af57-64882afceb3a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ba1a593e-f80b-5c5f-be50-5979b491bc70","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"c7814bac-b807-50ed-897b-50908d3dd092","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 9e8fa99b-e26c-4aba-90f1-3ff46620207a --><h3>What contraindications and cautions are associated with amoxicillin?</h3><!-- end field 9e8fa99b-e26c-4aba-90f1-3ff46620207a -->","summary":"","htmlStringContent":"<!-- begin item fa7a1dba-c214-4033-a441-ebb987364912 --><!-- begin field 7f72713d-2afe-474b-9390-6fb2f49dabc9 --><ul><li><strong>Do not prescribe amoxicillin to people with:</strong><ul><li>A true penicillin hypersensitivity — allergic reactions to penicillins occur in 1–10% of exposed individuals. Anaphylactic reactions occur in fewer than 0.05% of treated people.<ul><li>Gastrointestinal adverse effects alone (for example nausea, vomiting, or diarrhoea) do not constitute an allergy to penicillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for more information.</li></ul></li><li>Hypersensitivity to cephalosporins.</li></ul></li><li><strong>Prescribe amoxicillin with caution in people with:</strong><ul><li>Hepatic impairment.</li><li>Renal impairment — reduce the dose of amoxicillin in severe renal impairment.</li><li>Cytomegalovirus infection — increased risk of erythematous rashes.</li><li>Glandular fever (infective mononucleosis) — these people are especially susceptible to amoxicillin-induced skin rashes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">ABPI, 2020b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 7f72713d-2afe-474b-9390-6fb2f49dabc9 --><!-- end item fa7a1dba-c214-4033-a441-ebb987364912 -->","subChapters":[]},{"id":"e82d3450-1446-5ae8-8596-c9ab6d79f943","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 7be9ee64-4c97-4d06-9643-a696ddb1ca54 --><h3>What are the adverse effects of amoxicillin?</h3><!-- end field 7be9ee64-4c97-4d06-9643-a696ddb1ca54 -->","summary":"","htmlStringContent":"<!-- begin item 987c94a5-37a7-4a27-b8e5-36c1b5e55ecf --><!-- begin field a65a0901-1384-43ce-bd99-6a122aa231b9 --><ul><li><strong>Gastrointestinal </strong>— nausea, diarrhoea, vomiting (common). <ul><li>Very rarely: antibiotic-associated colitis.</li></ul></li><li><strong>Skin </strong>— skin rash (common), urticaria, pruritus (uncommon).<ul><li>Very rarely: erythema multiforme, Stevens–Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis, acute generalized exanthematous pustulosis.</li></ul></li><li>Other very rare adverse effects include:<ul><li>Hepatitis, cholestatic jaundice.</li><li>Hyperkinesia, dizziness, convulsions.</li><li>Interstitial nephritis.</li><li>Leucopenia, thrombocytopenia, haemolytic anaemia.</li><li>Severe allergic reactions.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">ABPI, 2020b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field a65a0901-1384-43ce-bd99-6a122aa231b9 --><!-- end item 987c94a5-37a7-4a27-b8e5-36c1b5e55ecf -->","subChapters":[]},{"id":"006c6feb-369b-587a-ad8c-dce191a6cb6b","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field fbf88a4c-2c0c-4e11-98e7-7655fede9b46 --><h3>What drug interactions are important with amoxicillin?</h3><!-- end field fbf88a4c-2c0c-4e11-98e7-7655fede9b46 -->","summary":"","htmlStringContent":"<!-- begin item a82e7d4d-cffa-457d-9636-b6007906d93d --><!-- begin field da9daaa9-b3e2-4005-8daa-84d962758581 --><ul><li><strong>Allopurinol</strong> — increased risk of rash when allopurinol is given with amoxicillin. </li><li><strong>Methotrexate</strong> — amoxicillin may reduce methotrexate clearance, causing an increased risk of toxicity.<ul><li>For people on high dose methotrexate, routine monitoring will identify any decreases in elimination. For people, on low dose methotrexate, consult local or national guidelines/protocols for recommendations on monitoring and management. </li></ul></li><li><strong>Oral anticoagulants (warfarin, phenindione)</strong> — international normalized ratio (INR) may be increased. Monitor the INR closely during concomitant use. Dosage adjustments may be necessary.  </li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are not required during or after courses of amoxicillin.<ul><li>However, women should be advised about the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the sections on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li><li><strong>Tetracyclines</strong> — the antibacterial effects of amoxicillin may be antagonized. Avoid concurrent use.</li><li><strong>Typhoid vaccine </strong>— antibacterials might reduce the immune response. The World Health Organization (WHO) recommends that the antibacterial is stopped from 3 days before to 3 days after receiving live oral typhoid vaccine.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bronchiectasis/references/\">Preston, 2020</a>]</p><!-- end field da9daaa9-b3e2-4005-8daa-84d962758581 --><!-- end item a82e7d4d-cffa-457d-9636-b6007906d93d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}